The effects of eplerenone on left ventricular remodelling post-acute myocardial infarction: a double-blind placebo-controlled cardiac MR-based study
Phase of Trial: Phase IV
Latest Information Update: 01 Jun 2009
At a glance
- Drugs Eplerenone (Primary)
- Indications Heart failure; Left ventricular dysfunction; Myocardial infarction
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 01 Jun 2009 Primary endpoint 'Left ventricular end systolic volume' has not been met.
- 31 Dec 2005 New trial record.